Nello Mainolfi insider trades: Kymera Therapeutics (KYMR) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Nello reports to the SEC
Open-market buys and sales
22 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | KYMR | ↓ Sell | 30,000 | $113.80 | $3.4M | Direct | Oct 1, 2026 (0d) |
| Jul 7, 2026 | KYMR | ↓ Sell | 50,000 | $119.00 | $6.0M | Direct | Jul 7, 2026 (0d) |
| Jul 1, 2026 | KYMR | ↓ Sell | 80,000 | $115.29 | $9.2M | Direct | Jul 2, 2026 (1d) |
| Apr 29, 2026 | KYMR | ↓ Sell | 30,000 | $81.18 | $2.4M | Direct | Apr 29, 2026 (0d) |
| Feb 25, 2026 | KYMR | ↓ Sell | 30,000 | $90.26 | $2.7M | Direct | Feb 25, 2026 (0d) |
| Dec 31, 2025 | KYMR | ↓ Sell | 30,000 | $78.06 | $2.3M | Direct | Dec 31, 2025 (0d) |
| Dec 8, 2025 | KYMR | ↓ Sell | 100,000 | $89.17 | $8.9M | Direct | Dec 8, 2025 (0d) |
| Oct 29, 2025 | KYMR | ↓ Sell | 30,000 | $60.99 | $1.8M | Direct | Oct 29, 2025 (0d) |
| Sep 16, 2025 | KYMR | ↓ Sell | 30,000 | $49.00 | $1.5M | Direct | Sep 16, 2025 (0d) |
| Jun 3, 2025 | KYMR | ↓ Sell | 30,000 | $49.00 | $1.5M | Direct | Jun 3, 2025 (0d) |
| Jan 12, 2022 | KYMR | ↓ Sell | 48,000 | $53.31 | $2.6M | Direct | Jan 12, 2022 (0d) |
| Oct 11, 2021 | KYMR | ↓ Sell | 48,000 | $56.34 | $2.7M | Direct | Oct 12, 2021 (1d) |
| Aug 4, 2021 | KYMR | ↓ Sell | 6,706 | $60.06 | $403K | Direct | Aug 5, 2021 (1d) |
| Aug 2, 2021 | KYMR | ↓ Sell | 30,415 | $60.25 | $1.8M | Direct | Aug 2, 2021 (0d) |
| Jul 28, 2021 | KYMR | ↓ Sell | 12,879 | $60.15 | $775K | Direct | Jul 28, 2021 (0d) |
| Jul 8, 2021 | KYMR | ↓ Sell | 48,000 | $49.70 | $2.4M | Direct | Jul 9, 2021 (1d) |
| Jun 10, 2021 | KYMR | ↓ Sell | 23,009 | $51.38 | $1.2M | Direct | Jun 11, 2021 (1d) |
| Jun 9, 2021 | KYMR | ↓ Sell | 18,746 | $50.10 | $939K | Direct | Jun 9, 2021 (0d) |
| May 12, 2021 | KYMR | ↓ Sell | 8,245 | $50.05 | $413K | Direct | May 14, 2021 (2d) |
| Apr 26, 2021 | KYMR | ↓ Sell | 14,407 | $40.23 | $580K | Direct | Apr 26, 2021 (0d) |
| Apr 19, 2021 | KYMR | ↓ Sell | 5,593 | $40.26 | $225K | Direct | Apr 19, 2021 (0d) |
| Apr 12, 2021 | KYMR | ↓ Sell | 48,000 | $33.62 | $1.6M | Direct | Apr 12, 2021 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other KYMR insiders
Open-market trades in the last 12 months
About Nello Mainolfi's insider trades
Nello Mainolfi is Chief Executive Officer at Kymera Therapeutics (KYMR). Since Apr 12, 2021, Nello has reported no open-market purchases and 22 sales worth $55.4M on SEC Form 4. In the last 12 months: 7 sales ($35.0M).
Their filings also include option exercises (39 filings), grants and awards (7 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KYMR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.